百花医药(600721)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600721 百花医药

已收盘 07-24 15:00:00

{"stockData":{"symbol":"600721","market":"SH","secType":"STK","nameCN":"百花医药","latestPrice":5.79,"timestamp":1721804400000,"preClose":6,"halted":0,"volume":22630445,"delay":0,"floatShares":382000000,"shares":382000000,"eps":0.0706,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.21,"latestTime":"07-24 15:00:00","open":5.88,"high":5.99,"low":5.78,"amount":133000000,"amplitude":0.035,"askPrice":5.8,"askSize":1712,"bidPrice":5.79,"bidSize":1422,"shortable":0,"etf":0,"ttmEps":0.0706,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721871000000},"adr":0,"adjPreClose":6,"symbolType":"stock","openAndCloseTimeList":[[1721784600000,1721791800000],[1721797200000,1721804400000]],"highLimit":6.6,"lowLimit":5.4,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":381993270,"pbRate":3.03,"roa":"--","roe":"2.88%","epsLYR":0.0342,"committee":0.113678,"marketValue":2212000000,"floatMarketCap":2212000000,"peRate":82.011328,"changeRate":-0.035,"turnoverRate":0.0592,"status":1},"requestUrl":"/m/hq/s/600721","defaultTab":"news","newsList":[{"id":"2453739579","title":"百花医药大涨5.15% 2023年第一季度业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2453739579","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453739579?lang=zh_cn&edition=full","pubTime":"2024-07-22 14:15","pubTimestamp":1721628920,"startTime":"0","endTime":"0","summary":"07月22日，百花医药股价大幅上涨，截至14点15分，百花医药上涨5.15%，报6.13元/股，成交1.37亿元，换手率6.05%，振幅6.52%。消息解读百花医药近期发布了2023年第一季度财报。财报显示，公司营收为1.2亿元，同比增长10.2%，净利润为2000万元，同比增长25.6%。最新财报显示，今年一季报，百花医药实现营业收入9,087.64万元，同比增长20.03%，净利润为2,066.35万元，同比增长209.02%，基本每股收益为0.05元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722141621aefab52c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722141621aefab52c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","600721","BK0102"],"gpt_icon":0},{"id":"2453862397","title":"百花医药撤回3.4亿定增：筹划三年，曾因实控人变更信披不及时“吃函”","url":"https://stock-news.laohu8.com/highlight/detail?id=2453862397","media":"地产k线","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453862397?lang=zh_cn&edition=full","pubTime":"2024-07-22 10:17","pubTimestamp":1721614642,"startTime":"0","endTime":"0","summary":"经查，百花医药、华凌工贸、华凌控股及百花医药实际控制人米在齐、米恩华、杨小玲在百花医药向特定对象发行股票申请过程中，存在违规情形。2024年2月8日，华凌工贸完成工商变更登记手续并取得营业执照。公司认定增加米在齐为公司实际控制人之一，公司实际控制人由米恩华、杨小玲变更为米在齐、米恩华、杨小玲。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221019339edd700a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407221019339edd700a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","600721","BK0102"],"gpt_icon":0},{"id":"2452264154","title":"上交所终止对百花医药向特定对象发行股票的审核","url":"https://stock-news.laohu8.com/highlight/detail?id=2452264154","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452264154?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:33","pubTimestamp":1721385234,"startTime":"0","endTime":"0","summary":"每经AI快讯，7月19日，新疆百花村医药集团股份有限公司和保荐人平安证券股份有限公司申请撤回向特定对象发行股票的申请文件和申请撤销向特定对象发行股票的保荐工作，上交所决定终止对其向特定对象发行股票的审核。文章来源：每日经济新闻原标题：上交所终止对百花医药向特定对象发行股票的审核","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071918491795dc4bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071918491795dc4bd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0102","BK0216","600721"],"gpt_icon":0},{"id":"2452446680","title":"百花医药(600721.SH)拟参投川渝高竹新区广易兴(重庆)私募股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2452446680","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452446680?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:03","pubTimestamp":1721376230,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百花医药(600721.SH)发布公告，公司全资子公司南京百花信生物医药科技有限公司(简称“百花信”)与四川药易购科技集团有限公司、广安投资集团有限公司、北京海量高科科技有限公司作为有限合伙人，广安小平故里发展基金管理有限公司、北京安龙创业投资基金(有限合伙)作为普通合伙人，共同出资设立川渝高竹新区广易兴(重庆)私募股权投资基金合伙企业(有限合伙)，百花信以自有资金认缴出资950万元，占标的基金认缴出资总额的7.60%。基金合伙协议于2024年7月18日签署。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600721","BK0216","BK0102"],"gpt_icon":0},{"id":"2450637485","title":"A股收评：沪指涨0.03%，超3100股下跌，换电、光伏、地产表现活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2450637485","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450637485?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:21","pubTimestamp":1720768905,"startTime":"0","endTime":"0","summary":"全天成交6870亿元，较昨日缩量1000亿元。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/101.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/101.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/849315","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0214","BK0266","BK0113","BK0102","BK0264","002285","BK0188","601918","600684","BK0028","BK0173","BK0065","BK0110","BK0140","BK0095","002981","BK0082","BK0216","BK0014","600721","300582","BK0273","BK0190","BK0201","600686","BK0010"],"gpt_icon":0},{"id":"2450372640","title":"百花医药上榜07月12日主力资金加仓幅度前10个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2450372640","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450372640?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:19","pubTimestamp":1720768767,"startTime":"0","endTime":"0","summary":"07月12日, 百花医药股价涨10.00%，报收6.05元，成交金额2.12亿元，换手率9.27%，振幅10.00%，量比2.03。百花医药今日主力资金净流入6549万元，上一交易日主力净流出383万元。该股近5个交易日上涨9.80%，主力资金累计净流入5049万元；近20日主力资金累计净流入7454万元，其中净流入天数为8日。该行业中净流入前三个股分别为百花医药、诺泰生物、昭衍新药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121533529f3a249c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121533529f3a249c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","BK0102","600721"],"gpt_icon":0},{"id":"2450732826","title":"CRO概念盘中拉升，百花医药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2450732826","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450732826?lang=zh_cn&edition=full","pubTime":"2024-07-12 10:41","pubTimestamp":1720752072,"startTime":"0","endTime":"0","summary":"07月12日，CRO概念盘中拉升，截至10点41分，CRO概念整体指数上涨1.05%，报335.590点。从个股上来看，该概念的成分股中，百花医药涨停，诺思格涨幅超过5%。从资金上来看，截止发稿，CRO概念主力净流入为6740.42万，其中百花医药受到资金热捧，主力净流入5409.18万；拉长时间线来看，该板块近20日主力资金净流入-38.50亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712104112aef957f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712104112aef957f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","BK0102","BK0216"],"gpt_icon":0},{"id":"2450340805","title":"新疆板块盘中拉升，百花医药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2450340805","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450340805?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:56","pubTimestamp":1720749400,"startTime":"0","endTime":"0","summary":"07月12日，新疆板块盘中拉升，截至09点56分，新疆板块整体指数上涨1.00%，报1265.980点。从个股上来看，该板块的成分股中，百花医药涨停，德新科技、汇嘉时代、国统股份涨幅居前。从资金上来看，截止发稿，新疆板块主力净流入为-2933.36万，其中百花医药受到资金热捧，主力净流入4614.58万；拉长时间线来看，该板块近20日主力资金净流入-35.01亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095640af91f672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095640af91f672&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","600721","BK0102"],"gpt_icon":0},{"id":"2450934233","title":"异动快报：百花医药（600721）7月12日9点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2450934233","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450934233?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:40","pubTimestamp":1720748449,"startTime":"0","endTime":"0","summary":"证券之星7月12日盘中消息，9点35分百花医药触及涨停板。目前价格6.05，上涨10.0%。其所属行业医疗服务目前上涨。领涨股为诺思格。该股为创新药，医药，干细胞概念热股，当日创新药概念上涨1.39%，医药概念上涨0.92%，干细胞概念上涨0.27%。7月11日的资金流向数据方面，主力资金净流出374.61万元，占总成交额2.84%，游资资金净流入705.36万元，占总成交额5.35%，散户资金净流出330.75万元，占总成交额2.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200015067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","600721","BK0216"],"gpt_icon":0},{"id":"2450428083","title":"新疆振兴概念盘中拉升，百花医药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2450428083","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450428083?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:40","pubTimestamp":1720748410,"startTime":"0","endTime":"0","summary":"07月12日，新疆振兴概念盘中拉升，截至09点40分，新疆振兴概念整体指数上涨1.00%，报731.780点。从个股上来看，该概念的成分股中，百花医药涨停，德新科技、美克家居、成都路桥涨幅居前。从资金上来看，截止发稿，新疆振兴概念主力净流入为2042.99万，其中百花医药受到资金热捧，主力净流入2915.13万；拉长时间线来看，该板块近20日主力资金净流入-30.34亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712094010941f6700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712094010941f6700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","600721","BK0102"],"gpt_icon":0},{"id":"2450340801","title":"减肥药概念股开盘走高 百花医药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2450340801","media":"南方财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450340801?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:39","pubTimestamp":1720748350,"startTime":"0","endTime":"0","summary":"盘中异动南方财经7月12日电，百花医药涨停，博济医药、金凯生科、圣诺生物、昊帆生物、博腾股份、阳光诺和、常山药业等跟涨。消息面上，辉瑞公司(PFE.US)正在推进一款减肥药的研发，这家制药商正试图打入数十亿美元的减肥药市场。文章来源：南方财经网原标题：减肥药概念股开盘走高 百花医药涨停","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120957059f387306&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120957059f387306&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","600721","BK0102"],"gpt_icon":0},{"id":"2450872469","title":"肝炎概念盘中拉升，百花医药涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450872469","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450872469?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:05","pubTimestamp":1720663500,"startTime":"0","endTime":"0","summary":"07月11日，肝炎概念盘中拉升，截至10点04分，肝炎概念整体指数上涨2.04%，报740.350点。从个股上来看，该概念的成分股中，百花医药涨5.56%，凯普生物、普蕊斯、凯因科技涨幅居前。从资金上来看，截止发稿，肝炎概念概念主力净流入为2094.19万，其中科伦药业受到资金热捧，主力净流入998.73万；拉长时间线来看，该板块近20日主力资金净流入-20.79亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711100500aef91986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711100500aef91986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0102","600721","BK0216"],"gpt_icon":0},{"id":"2450894168","title":"百花医药最新公告：预计上半年净利同比增长35%-103%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450894168","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450894168?lang=zh_cn&edition=full","pubTime":"2024-07-10 20:40","pubTimestamp":1720615235,"startTime":"0","endTime":"0","summary":"百花医药公告，公司预计2024年上半年实现归属于上市公司股东的净利润1760万元至2640万元，同比增加35.38%到103.08%。与上年同期相比，公司进一步划小核算单元、细化激励考核，提升项目的研发效率，推进的研发项目数量增加，项目交付的周期缩短，使得固定成本得以摊薄，项目毛利有所提升，带来公司利润的增长。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000044496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0216","BK0102"],"gpt_icon":0},{"id":"2450863813","title":"百花医药(600721.SH)：预计半年度净利润同比增加35.38%到103.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450863813","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450863813?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:36","pubTimestamp":1720600601,"startTime":"0","endTime":"0","summary":"格隆汇7月10日丨百花医药(600721.SH)公布，经公司财务部门初步测算，预计2024年半年度实现归属于上市公司股东的净利润1,760万元至2,640万元，与上年同期相比，将增加460万元至1,340万元，同比增加35.38%到103.08%。公司预计2024年半年度实现归属于上市公司股东的扣除非经常损益的净利润为1,650万元至2,450万元，同比增加34.40%到99.56%。与上年同期相比，公司进一步划小核算单元、细化激励考核，提升项目的研发效率，推进的研发项目数量增加，项目交付的周期缩短，使得固定成本得以摊薄，项目毛利有所提升，带来公司利润的增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101636489f2bc2ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101636489f2bc2ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721"],"gpt_icon":0},{"id":"2450685079","title":"百花医药(600721.SH)发预增，预计上半年净利润1760万元至2640万元，同比增加35.38%到103.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450685079","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450685079?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:36","pubTimestamp":1720600592,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百花医药(600721.SH)发布2024年半年度业绩预告，预计2024年半年度实现归属于上市公司股东的净利润1760万元至2640万元，与上年同期相比，将增加460万元至1340万元，同比增加35.38%到103.08%。公司预计2024年半年度实现归属于上市公司股东的扣除非经常损益的净利润为1650万元至2450万元，同比增加34.40%到99.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600721"],"gpt_icon":0},{"id":"2449212911","title":"实控人变更未信披 百花医药定增“落空”","url":"https://stock-news.laohu8.com/highlight/detail?id=2449212911","media":"中国经营网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449212911?lang=zh_cn&edition=full","pubTime":"2024-07-06 04:41","pubTimestamp":1720212060,"startTime":"0","endTime":"0","summary":"按照百花医药的披露，华凌工贸是影响此次定增终止的主要因素。事实上，百花医药定增只差“临门一脚”之际，华凌工贸内部暗流涌动。6月7日，上交所对百花医药控股股东及实控人通报批评；6月17日，百花医药公告收到新疆证监局警示函。未及时信披“吃函”自成立以来，百花医药维持经营离不开融资。上交所对百花医药控股股东及实控人纪律处分决定书显示，上述实控人变更事项发生在上交所对公司定增申请审核期间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407060442119f0d0913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407060442119f0d0913&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","BK0102","BK0216"],"gpt_icon":0},{"id":"2448341334","title":"百花医药（600721）7月4日主力资金净卖出866.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448341334","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448341334?lang=zh_cn&edition=full","pubTime":"2024-07-04 15:15","pubTimestamp":1720077341,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月4日收盘，百花医药报收于5.35元，下跌5.48%，换手率5.7%，成交量21.78万手，成交额1.18亿元。7月4日的资金流向数据方面，主力资金净流出866.82万元，占总成交额7.36%，游资资金净流出982.01万元，占总成交额8.34%，散户资金净流入1848.82万元，占总成交额15.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400024108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600721","BK0102","BK0216"],"gpt_icon":0},{"id":"2448464183","title":"百花医药大跌5.12% 主力净流出706万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448464183","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448464183?lang=zh_cn&edition=full","pubTime":"2024-07-04 10:39","pubTimestamp":1720060778,"startTime":"0","endTime":"0","summary":"07月04日，百花医药股价大幅下跌，截至10点39分，百花医药下跌5.12%，报5.37元/股，成交6721万元，换手率3.23%。资金动向截止发稿，百花医药获得主力净流出706万元，其中超大单流入137万元，大单流出843万元。数据显示，该股今日净流入较近5日净流入均值减少308万元。最新财报显示，今年一季报，百花医药实现营业收入9,087.64万元，同比增长20.03%，净利润为2,066.35万元，同比增长209.02%，基本每股收益为0.05元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704103959aef7df4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704103959aef7df4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","BK0102","600721"],"gpt_icon":0},{"id":"2448093138","title":"一家药企拟终止定向增发事项！去年和今年一季度均实现盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2448093138","media":"中国制药网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448093138?lang=zh_cn&edition=full","pubTime":"2024-07-01 10:15","pubTimestamp":1719800100,"startTime":"0","endTime":"0","summary":"6月28日晚间， 百花医药 发布公告称，公司于2024年6月28日召开第八届董事会第二十六次会议，审议通过了《关于公司与新疆华凌国际医疗产业发展有限公司签署的议案》。本次百花医药涉及的再融资项目是2021年度向特定对象发行股票。值得一提的是，去年和今年一季度，公司实现盈利。同时，2024年一季报显示，今年一季度，百花医药实现营业收入9087.64万元，较上年同期增长20.03%，归母净利润为2066.35万元，较上年同期增加209.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701101926955b6d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701101926955b6d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","BK0102","BK0216"],"gpt_icon":0},{"id":"2448333931","title":"肝炎概念盘中跳水，百花医药跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448333931","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448333931?lang=zh_cn&edition=full","pubTime":"2024-07-01 10:07","pubTimestamp":1719799678,"startTime":"0","endTime":"0","summary":"07月01日，肝炎概念盘中跳水，截至10点07分，肝炎概念整体指数下跌1.01%，报732.300点。从个股上来看，该概念的成分股中，百花医药跌0.17%，跌幅居前。从资金上来看，截止发稿，肝炎概念概念主力净流入为-4235.20万，其中特宝生物受到资金热捧，主力净流入576.35万；拉长时间线来看，该板块近20日主力资金净流入-24.87亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701100758aef74b1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701100758aef74b1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0102","BK0216","600721"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-06-26","address":"新疆维吾尔自治区五家渠市东工业园区纬六西街699号研发办公楼3号","stockEarnings":[{"period":"1week","weight":0.0256},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.1299},{"period":"6month","weight":-0.1189},{"period":"1year","weight":-0.1724},{"period":"ytd","weight":-0.2248}],"companyName":"新疆百花村医药集团股份有限公司","boardCode":"AI0073","perCapita":"12297股","boardName":"研究和试验发展","registeredCapital":"38199万元","compareEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.0276},{"period":"3month","weight":-0.0425},{"period":"6month","weight":0.0032},{"period":"1year","weight":-0.0786},{"period":"ytd","weight":-0.02}],"survey":"　　新疆百花村医药集团股份有限公司主营业务涵盖新药早期发现与筛选、药物CMC开发、临床试验、注册申报、BE/PK生物样品分析及药学检测服务、临床SMO及数据服务、MAH服务、API及中间体生产供应，为客户提供从药物发现、药学CMC开发、临床试验与申报注册的全过程一站式外包和技术成果转化服务。公司主要产品为医药研发、临床试验等。其化仿新药申报数量连年居行业前列、在医药全行业（含医药生产）研发能力评比中名列前茅。公司创立二十年来，专注于药物的专业研发，具有缓释技术、靶向给药系统、新分子药物筛选、手性合成等多项前沿技术平台的技术核心竞争力，是医药行业细分研发类中的小龙头企业。","serverTime":1721820282779,"listedPrice":4.2,"stockholders":"31063人(较上一季度增加26.46%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百花医药(600721)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百花医药(600721)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百花医药,600721,百花医药股票,百花医药股票老虎,百花医药股票老虎国际,百花医药行情,百花医药股票行情,百花医药股价,百花医药股市,百花医药股票价格,百花医药股票交易,百花医药股票购买,百花医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百花医药(600721)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百花医药(600721)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}